# FDA recall D-1178-2017

> **Teva Pharmaceuticals USA** · Class II · drug recall initiated 2017-09-05.

## Product

Acarbose Tablets, 25 mg, 100-count bottle, Rx only, Manufactured by: Arrow Pharm (Malta) Ltd., Birzebbugia BBG3000, Malta; Distributed by: Actavis Pharma, Inc., Parsippany, NJ  07054; NDC 16252-523-01.

## Reason for recall

Labeling: Incorrect or Missing Lot and/or Exp Date: An incorrect expiration date of July 2018 is printed on the product labeling rather than the correct expiration date of July 2017.

## Distribution

Nationwide in the USA

## Key facts

- **Recall number:** D-1178-2017
- **Recalling firm:** Teva Pharmaceuticals USA
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2017-09-05
- **Report date:** 2017-10-04
- **Termination date:** 2018-06-21

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** North Wales, PA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1178-2017

## Citation

> AI Analytics. FDA recall D-1178-2017. Retrieved 2026-07-15 from https://api.ai-analytics.org/recall/D-1178-2017. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*